<?xml version="1.0" encoding="UTF-8"?>
<p id="p0025">Viral myocarditis (VMC) is a disorder that affects the myocardiocytes following a viral infection and can progress into dilated cardiomyopathy and heart failure in young adults [
 <xref rid="bib1" ref-type="bibr">1</xref>]. Coxsackievirus B3 (CVB3), a member of the 
 <italic>Enterovirus</italic> genus of Picornaviridae, is well-identified as the dominant etiological factor causing viral myocarditis. It was reported that about 25â€“27% cases of dilated cardiomyopathy and VMC in young adults and children were caused by CVB3 [
 <xref rid="bib2" ref-type="bibr">2</xref>,
 <xref rid="bib3" ref-type="bibr">3</xref>]. Although type-I interferon is reported to have certain therapeutic effect, the treatment or vaccine has been successful in treating CVB3 infection and myocarditis [
 <xref rid="bib4" ref-type="bibr">4</xref>,
 <xref rid="bib5" ref-type="bibr">5</xref>].
</p>
